Leyden Labs Funding: $215M Raised, Series A (2025)
Leyden Labs is a Biotech company based in Amsterdam, Netherlands. It has raised $215M in total funding. Latest round: Series A.
Leyden Labs funding overview
Leyden Labs is a Biotech company based in Amsterdam, Netherlands. Leyden Labs has raised $215M in total disclosed funding. That places its disclosed total in the $100M–$250M range. Its most recent disclosed round is a Series A announced in February 2025. The round record for Leyden Labs runs through 2025; nothing later has been disclosed. Investors on record include GV (formerly Google Ventures), F-Prime Capital, Casdin Capital, European Innovation Council Fund, Invest-NL, Gates Foundation Strategic Investment Fund and 2 others. 8 distinct backers are named across the disclosed rounds.
Leyden Labs at a glance
Total raised
$215M
Latest round
Series A
Latest round date
February 2025
Industry
Biotech
Headquarters
Amsterdam, Netherlands
Notable investors
GV (formerly Google Ventures), F-Prime Capital, Casdin Capital, European Innovation Council Fund, Invest-NL, Gates Foundation Strategic Investment Fund, ClavystBio, Brook Byers
Frequently asked about Leyden Labs funding
How much has Leyden Labs raised?
Leyden Labs has raised $215M in total disclosed funding across the rounds on record.
Who has invested in Leyden Labs?
GV (formerly Google Ventures), F-Prime Capital, Casdin Capital, European Innovation Council Fund, Invest-NL, Gates Foundation Strategic Investment Fund are named among the investors backing Leyden Labs.
What was the latest Leyden Labs funding round?
The most recent disclosed round is a Series A, announced in February 2025.
Where is Leyden Labs based?
Leyden Labs is based in Amsterdam, Netherlands.
What sector does Leyden Labs operate in?
Leyden Labs is tracked under Biotech from Amsterdam, Netherlands, with $215M in disclosed funding.
When did Leyden Labs last raise?
The last disclosed Leyden Labs round closed in February 2025 at Series A.
Totals shown for Leyden Labs aggregate every disclosed round on file. To see how that compares, browse the Biotech companies in Amsterdam and the investors behind them below.
